J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
J1620 is a HCPCS Level II code for injection, gonadorelin hydrochloride, per 100 mcg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J1620 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1620
- Long descriptor
- Injection, gonadorelin hydrochloride, per 100 mcg
- Short descriptor
- Gonadorelin hydroch/ 100 mcg
- Added
- January 1, 1982
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J1620
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1620 is not quite right, the correct code is very often within a few positions of it.
- J1597Injection, glycopyrrolate (glyrx-pf), 0.1 mg
- J1598Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
- J1599Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- J1600Injection, gold sodium thiomalate, up to 50 mg
- J1602Injection, golimumab, 1 mg, for intravenous use
- J1610Injection, glucagon hydrochloride, per 1 mg
- J1611Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612Injection, glucagon (gvoke), 0.01 mg
- J1626Injection, granisetron hydrochloride, 100 mcg
- J1627Injection, granisetron, extended-release, 0.1 mg
- J1628Injection, guselkumab, 1 mg
- J1630Injection, haloperidol, up to 5 mg
- J1631Injection, haloperidol decanoate, per 50 mg
- J1632Injection, brexanolone, 1 mg
- J1640Injection, hemin, 1 mg
- J1642Injection, heparin sodium, (heparin lock flush), per 10 units
Questions about J1620
What is HCPCS code J1620?
J1620 is a HCPCS Level II code for injection, gonadorelin hydrochloride, per 100 mcg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1620?
The CMS HCPCS file marks J1620 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J1620 still valid?
No. J1620 was terminated on December 31, 2025 and should not be used on new claims.